MK-1708

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Alzheimer's DiseaseHealthy

Phase 1

A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003)

CompletedNCT06586606

Merck Sharp & Dohme LLCAlzheimer's Disease

Start: 2024-10-03End: 2024-12-10Updated: 2024-12-18

A Clinical Study of MK-1708 in Healthy Elderly Participants (MK-1708-005)

CompletedNCT06647628

Merck Sharp & Dohme LLCHealthy

Start: 2024-11-04End: 2025-03-31Updated: 2025-05-15